Arbutus Biopharma shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Arbutus Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Arbutus Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Arbutus Biopharma by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $446k | 98k | 4.54 |
| 2025-03-31 | $1.9M | 539k | 3.49 |
| 2024-12-31 | $2.9M | 896k | 3.27 |
| 2024-09-30 | $345k | 90k | 3.85 |
| 2024-06-30 | $249k | 81k | 3.09 |
| 2024-03-31 | $227k | 88k | 2.58 |
| 2023-12-31 | $289k | 116k | 2.50 |
| 2023-09-30 | $242k | 119k | 2.03 |
| 2023-06-30 | $242k | 105k | 2.30 |
| 2023-03-31 | $627k | 207k | 3.03 |
| 2022-12-31 | $170k | 73k | 2.34 |
| 2022-06-30 | $169k | 64k | 2.63 |
| 2022-03-31 | $175k | 59k | 2.96 |
| 2021-12-31 | $166k | 43k | 3.89 |
| 2021-03-31 | $0 | 35k | 0.00 |
| 2020-12-31 | $0 | 36 | 0.00 |
| 2020-06-30 | $0 | 33 | 0.00 |
| 2019-09-30 | $145k | 95k | 1.52 |
| 2019-06-30 | $688k | 304k | 2.26 |
| 2019-03-31 | $2.8M | 778k | 3.58 |
| 2018-12-31 | $46k | 12k | 3.88 |
| 2018-09-30 | $979k | 104k | 9.45 |
| 2018-06-30 | $1.6M | 218k | 7.25 |
| 2018-03-31 | $1.1M | 222k | 5.00 |
| 2017-12-31 | $898k | 178k | 5.05 |
| 2017-06-30 | $24k | 6.7k | 3.60 |
| 2017-03-31 | $25k | 7.6k | 3.29 |
| 2016-12-31 | $24k | 9.7k | 2.47 |
| 2016-06-30 | $6.0k | 1.4k | 4.29 |